Robert Elsby
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 18
- Drug Transport and Resistance Mechanisms 18
-
- Pharmacological Effects and Toxicity Studies 11
- Co-authors
- Katherine S. Fenner (5 shared papers)Dominic Surry (9 shared papers)Constanze Hilgendorf (2 shared papers)Pradeep Sharma (7 shared papers)Neil R. Kitteringham (4 shared papers)James L. Maggs (3 shared papers)John Ashby (3 shared papers)Christopher E. Goldring (2 shared papers)
- Journals
- Drug Metabolism and Disposition (3 papers)Xenobiotica (3 papers)PROTEOMICS (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Pharmacology Research & Perspectives (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Robert Elsby
28 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Pharmacology 542
- Oncology 730
- Pediatrics, Perinatology and Child Health 342
- Hepatology 92
- Health, Toxicology and Mutagenesis 149
Countries citing papers authored by Robert Elsby
This map shows the geographic impact of Robert Elsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Elsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Elsby more than expected).
Fields of papers citing papers by Robert Elsby
This network shows the impact of papers produced by Robert Elsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Elsby. The network helps show where Robert Elsby may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Elsby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 201 | |
| 2 | 2004 | 177 | |
| 3 | 2012 | 170 | |
| 4 | 2003 | 134 | |
| 5 | 2015 | 126 | |
| 6 | 2008 | 109 | |
| 7 | 2015 | 100 | |
| 8 | 2001 | 97 | |
| 9 | 2015 | 88 | |
| 10 | 2006 | 61 | |
| 11 | 2012 | 47 | |
| 12 | 2016 | 41 | |
| 13 | 2017 | 40 | |
| 14 | 2000 | 37 | |
| 15 | 2003 | 36 | |
| 16 | 2001 | 32 | |
| 17 | 2011 | 31 | |
| 18 | 2009 | 27 | |
| 19 | 2011 | 26 | |
| 20 | 2010 | 20 |
About Robert Elsby
Robert Elsby is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Pharmacology, Infectious Diseases and Molecular Biology, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), Pharmacological Effects and Toxicity Studies (11 papers), Pharmacogenetics and Drug Metabolism (9 papers), HIV/AIDS drug development and treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Glutathione Transferases and Polymorphisms (3 papers). The work is most often cited by research in Pharmacology (542 citations), Oncology (730 citations), Pediatrics, Perinatology and Child Health (342 citations), Hepatology (92 citations) and Health, Toxicology and Mutagenesis (149 citations). Robert Elsby has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Katherine S. Fenner, Dominic Surry, Constanze Hilgendorf, Pradeep Sharma, Neil R. Kitteringham, James L. Maggs, John Ashby, Christopher E. Goldring, B. Kevin Park and Sarah R. Bujac. Their work appears in journals such as Drug Metabolism and Disposition, Xenobiotica, PROTEOMICS, Journal of Pharmacology and Experimental Therapeutics and Pharmacology Research & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.